577 related articles for article (PubMed ID: 15494904)
1. A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection.
Schrenzel J; Harbarth S; Schockmel G; Genné D; Bregenzer T; Flueckiger U; Petignat C; Jacobs F; Francioli P; Zimmerli W; Lew DP;
Clin Infect Dis; 2004 Nov; 39(9):1285-92. PubMed ID: 15494904
[TBL] [Abstract][Full Text] [Related]
2. Oral step-down therapy is comparable to intravenous therapy for Staphylococcus aureus osteomyelitis.
Daver NG; Shelburne SA; Atmar RL; Giordano TP; Stager CE; Reitman CA; White AC
J Infect; 2007 Jun; 54(6):539-44. PubMed ID: 17198732
[TBL] [Abstract][Full Text] [Related]
3. [Cotrimoxazole plus rifampicin in the treatment of staphylococcal osteoarticular infection].
Sánchez C; Matamala A; Salavert M; Cuchí E; Pons M; Anglés F; Garau J
Enferm Infecc Microbiol Clin; 1997 Jan; 15(1):10-3. PubMed ID: 9147500
[TBL] [Abstract][Full Text] [Related]
4. Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment: a prospective and randomized clinical trial of 381 patients.
Ruotsalainen E; Järvinen A; Koivula I; Kauma H; Rintala E; Lumio J; Kotilainen P; Vaara M; Nikoskelainen J; Valtonen V;
J Intern Med; 2006 Feb; 259(2):179-90. PubMed ID: 16420547
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy and safety of oral fleroxacin and amoxicillin/clavulanate potassium in skin and soft tissue infections.
Tassler H
Am J Med; 1993 Mar; 94(3A):159S-165S. PubMed ID: 8452174
[TBL] [Abstract][Full Text] [Related]
6. Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children.
Kaplan SL; Deville JG; Yogev R; Morfin MR; Wu E; Adler S; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB;
Pediatr Infect Dis J; 2003 Aug; 22(8):677-86. PubMed ID: 12913766
[TBL] [Abstract][Full Text] [Related]
7. Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic.
Cosgrove SE; Vigliani GA; Fowler VG; Abrutyn E; Corey GR; Levine DP; Rupp ME; Chambers HF; Karchmer AW; Boucher HW
Clin Infect Dis; 2009 Mar; 48(6):713-21. PubMed ID: 19207079
[TBL] [Abstract][Full Text] [Related]
8. Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem.
Jang HC; Kim SH; Kim KH; Kim CJ; Lee S; Song KH; Jeon JH; Park WB; Kim HB; Park SW; Kim NJ; Kim EC; Oh MD; Choe KW
Clin Infect Dis; 2009 Aug; 49(3):395-401. PubMed ID: 19569970
[TBL] [Abstract][Full Text] [Related]
9. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.
Fowler VG; Boucher HW; Corey GR; Abrutyn E; Karchmer AW; Rupp ME; Levine DP; Chambers HF; Tally FP; Vigliani GA; Cabell CH; Link AS; DeMeyer I; Filler SG; Zervos M; Cook P; Parsonnet J; Bernstein JM; Price CS; Forrest GN; Fätkenheuer G; Gareca M; Rehm SJ; Brodt HR; Tice A; Cosgrove SE;
N Engl J Med; 2006 Aug; 355(7):653-65. PubMed ID: 16914701
[TBL] [Abstract][Full Text] [Related]
10. Linezolid for the treatment of methicillin-resistant Staphylococcus aureus infections in children.
Kaplan SL; Afghani B; Lopez P; Wu E; Fleishaker D; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S178-85. PubMed ID: 14520144
[TBL] [Abstract][Full Text] [Related]
11. Open trial of oral fleroxacin versus amoxicillin/clavulanate in the treatment of infections of skin and soft tissue.
Powers RD
Am J Med; 1993 Mar; 94(3A):155S-158S. PubMed ID: 8452173
[TBL] [Abstract][Full Text] [Related]
12. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.
Hidayat LK; Hsu DI; Quist R; Shriner KA; Wong-Beringer A
Arch Intern Med; 2006 Oct; 166(19):2138-44. PubMed ID: 17060545
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
Tsaganos T; Skiadas I; Koutoukas P; Adamis T; Baxevanos N; Tzepi I; Pelekanou A; Giamarellos-Bourboulis EJ; Giamarellou H; Kanellakopoulou K
J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576
[TBL] [Abstract][Full Text] [Related]
14. Linezolid eradicates MRSA better than vancomycin from surgical-site infections.
Weigelt J; Kaafarani HM; Itani KM; Swanson RN
Am J Surg; 2004 Dec; 188(6):760-6. PubMed ID: 15619496
[TBL] [Abstract][Full Text] [Related]
15. Levofloxacin plus rifampicin conservative treatment of 25 early staphylococcal infections of osteosynthetic devices for rigid internal fixation.
Barberán J; Aguilar L; Giménez MJ; Carroquino G; Granizo JJ; Prieto J
Int J Antimicrob Agents; 2008 Aug; 32(2):154-7. PubMed ID: 18571387
[TBL] [Abstract][Full Text] [Related]
16. Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus.
Sharpe JN; Shively EH; Polk HC
Am J Surg; 2005 Apr; 189(4):425-8. PubMed ID: 15820454
[TBL] [Abstract][Full Text] [Related]
17. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study.
Chang FY; Peacock JE; Musher DM; Triplett P; MacDonald BB; Mylotte JM; O'Donnell A; Wagener MM; Yu VL
Medicine (Baltimore); 2003 Sep; 82(5):333-9. PubMed ID: 14530782
[TBL] [Abstract][Full Text] [Related]
18. Linezolid versus vancomycin for Staphylococcus aureus bacteraemia: pooled analysis of randomized studies.
Shorr AF; Kunkel MJ; Kollef M
J Antimicrob Chemother; 2005 Nov; 56(5):923-9. PubMed ID: 16195255
[TBL] [Abstract][Full Text] [Related]
19. Comparison of oral fleroxacin with oral amoxicillin/clavulanate for treatment of skin and soft tissue infections.
Smith JW; Nichols RL
Am J Med; 1993 Mar; 94(3A):150S-154S. PubMed ID: 8452172
[TBL] [Abstract][Full Text] [Related]
20. Successful therapy of experimental chronic foreign-body infection due to methicillin-resistant Staphylococcus aureus by antimicrobial combinations.
Chuard C; Herrmann M; Vaudaux P; Waldvogel FA; Lew DP
Antimicrob Agents Chemother; 1991 Dec; 35(12):2611-6. PubMed ID: 1810196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
